Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 11, 1999, Pages 1467-1471

  Fouad, Y M ^a   Katz, P O ^a   Castell, D O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; MANOMETRY; NIGHT SLEEP; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH ACID; STOMACH ACID SECRETION; STOMACH PH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; ENZYME INHIBITORS; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGOGASTRIC JUNCTION; ESOPHAGUS; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMPS;

EID: 0032722974     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00641.x     Document Type: Article

References (12)

1. 1 Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1998; 93: 763-7.
2. 2 Hatlebakk JG, Katz PO, Kuo B, Castell DO. Nocturnal gastric acidity and acid breakthrough in different regimens of omeprazole 40 mg daily. Alim Pharm Ther 1998; 12: 1235-40.
3. 3 Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93: 763-7.
4. 4 Leite LP, Johnston BT, Just RJ, Castell DO. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996; 91: 1527-31.
5. 5 Katz PO, Anderson C, Khoury R, Castell DO. Gastroesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharm Ther 1998; 12: 1231-4.
6. 6 Johnson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol 1987; 9: 23-7.
7. 7 Katzka DA, Castell DO. Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus. Am J Gastroenterol 1994; 89: 989-91.
8. 8 Castell JA, Gideon RM, Castell DO. Esophagus. In Schuster M, eds. Atlas of Gastrointestinal Motility in Health and Disease. Baltimore: Williams & Wilkins, 1993: 134-57.
9. 9 Leite LP, Johnston BT, Barrett J, Castell JA, Castell DO. Ineffective esophageal motility (IEM): The primary finding in patients with non specific csophageal motility disorder. Dig Dis Sci 1997; 42: 1859-65.
10. 10 Fouad YM, Katz PO, Khoury R, Castell DO. Ineffective esophageal motility (IEM) is more prevalent in reflux patients with respiratory symptoms. Am J Gastroenterol 1999; 94: 1464-7.
11. 11 Fitzgerald RC, Omary MR, Triadafilopoulos G. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation differentiation model. J Clin Invest 1996; 98: 2120-8.
12. 12 Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998; 115: 1335-9.